What is the intrinsic value of a stock?

The reference method for calculating intrinsic value is discounted cash flow (DCF). It consists of projecting the free cash the company will generate over the coming years, adding a terminal value that captures the later flows, and bringing it all to present value with a discount rate that reflects risk. The result is what that future stream of cash is worth today.

The three levers that move the result the most are the growth of the flows, the cash margin and the discount rate (WACC). Small changes in any of them alter the intrinsic value a lot, which makes the DCF as powerful as it is dangerous: it is easy to 'manufacture' the value you want by choosing assumptions to suit. Hence the importance of them being realistic and transparent.

DeepTicker calculates with professional rigour but explains it in clear language: it uses the real WACC by industry from public references on cost of capital by sector (advertising ~7.8%, banks ~5%, software ~9.5%, utilities ~6%) instead of a generic percentage, because using the correct WACC can change the estimated value between 15% and 30%. And it models growth in several phases that moderate over time, instead of assuming eternal high growth that no company sustains.

The market price is what a stock costs today according to supply and demand; the intrinsic value is what that stock is worth according to the fundamentals of the business. The two sometimes coincide, but frequently diverge, especially in moments of euphoria or panic when emotions dominate the market. That divergence is precisely the source of opportunity for the value investor.

Benjamin Graham illustrated it with his famous 'Mr. Market' metaphor: a manic-depressive partner who every day offers to buy from you or sell you your stake at a different price, sometimes euphoric and sometimes depressed. The intelligent investor does not let himself be dragged along by his mood, but buys when the price is well below the intrinsic value and sells when it is well above.

DeepTicker materialises this philosophy by showing you, for each stock, not only the price but what that price demands in terms of growth and margin (Reverse DCF). That way you stop looking at the price in isolation and start comparing it with a defensible value. The difference between the two is, in essence, your margin of safety or your overpayment.

The margin of safety is the difference between the estimated intrinsic value and the price you pay. If a company is worth around €100 per share according to your calculations and you buy it at €65, you have a margin of safety of 35%: a cushion that protects you if your estimates were too optimistic or if the business suffers a setback. Graham considered the margin of safety the central concept of all sensible investing.

The reason for demanding a margin is humility: no one calculates intrinsic value with precision, because it depends on the future, which is uncertain. The greater the margin of safety, the more room you have to be wrong without losing money. Buying right at the estimated intrinsic value leaves no cushion; buying well below does.

On DeepTicker, the valuation verdict (Bargain, Reasonable, Demanding, Expensive, Priced-in bubble) directly translates the relationship between price and implied intrinsic value, which gives you an immediate read on whether a margin of safety exists. That said, remember to always combine the valuation with the quality of the business (DeepScore): a margin of safety over a fragile company can be a value trap, not a bargain.

Intrinsic value calculated by classic DCF works well in companies with relatively stable and predictable cash flows, but not in all businesses. In banks, for example, free cash flow does not have the same meaning and other metrics are used: P/B, ROE and the Tier 1 capital ratio. Forcing a DCF here gives misleading numbers.

The same happens with REITs (where you use FFO/AFFO, cap rate and yield), revenue-less biotech (whose value lies in its pipeline and cash, not in current flows) or recently listed companies, without enough track record. In all these cases, an intrinsic value by DCF is more noise than signal.

DeepTicker has an honesty by type of company that few tools offer: it detects when it is facing a bank, a REIT, a biotech or a recent IPO and, instead of spitting out a misleading intrinsic value, tells you what to look at instead. That transparency —recognising the limits of the method— is part of investing with criteria, and it is what distinguishes rigorous analysis from a pretty number with no foundation.